Search Results

Centauri Therapeutics Limited, an immunotherapy company focused on the treatment of infectious diseases, announced three senior appointments: Dr Jennifer Schneider as Chief Executive Officer, Dr Helen Bright as Vice President of Research & Development, and Professor David Roblin FRCP FMedSci as Chair of the Board of Directors.

Centauri Therapeutics Limited, an immunotherapy company founded by Animatrix Founders LLP and focused on the treatment of infectious diseases, announced the close of its £24 million GBP Series A investment round.

Galaxy Medical announced that it received the CE Mark for its CENTAURI Pulsed Electric Field System and launched its commercial program.

Roche’s reorganization of Spark Therapeutics is coming more into focus, with nearly 300 employees being let go by the end of this year. Spark also trimmed its staff in 2024.

We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system

Centauri Therapeutics, an immunotherapy company active in oncology and infectious diseases, announces that it will attend the following scientific and investor conferences

The latest Repare Therapeutics layoffs will include its chief medical officer and could leave the biotech with fewer than 35 employees as it works to advance two Phase I clinical programs.